VS
V SrivatsaFund Manager Since 3 Mar 2017
EquitySector - Healthcare
UTI Healthcare Fund-Growth Option- Direct
3Y Annualised
24.78%
-0.49% 1D
Fund Performance
Fund Multiplier
Fund Info
Peer Comparison
Fund Managers
AMC Details
Performance
1M Returns
-2.23%
-0.49% 1D
Benchmark
N/A
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
This Fund
3 years 2 months
NIFTY 50
5 years 3 months
FD
9 years 7 months
Fund info
Fund size
₹1101.63 Cr
Min. SIP amount
₹500
Min. Lumpsum amount
₹5000
Exit load
0.01%
Period of Holding < 30 - 1%, Period of Holding = 30 days - Nil
Risk Profile
Very High Risk
Peer Comparison
This Fund's Performance Compared With Peers
Over the Period of oneMonth
1st
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
0.09%
2nd
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
0.09%
3rd
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
0.09%
4th
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth
-0.03%
5th
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Reinvestment Inc Dist cum Cap Wdrl
-0.05%
106th
UTI Healthcare Fund-Growth Option- Direct
-2.23%
Fund Managers
KG
Kamal GadaFund Manager Since 2 May 2022
About UTI Healthcare Fund-Growth Option- Direct
UTI Healthcare Fund-Growth Option- Direct is a Equity mutual fund scheme from UTI Asset Management Co Ltd. This fund has been in existence for 13 years, having been launched on 2013-01-01. UTI Healthcare Fund-Growth Option- Direct has ₹1101.63 Cr worth of assets under management (AUM) as of Tue Jan 13 2026. The latest Net Asset Value (NAV) of UTI Healthcare Fund-Growth Option- Direct as of Mon Jan 12 2026 is ₹317.923. The fund has an expense ratio of 1.29%, which is medium comparable to most other Equity funds.
UTI Healthcare Fund-Growth Option- Direct returns for the last 1 year are -0.58%. Since launch, it has delivered 15.67% average annual returns.
The UTI Healthcare Fund-Growth Option- Direct has the majority of its money invested in Healthcare sectors.
Top 5 Holdings of UTI Healthcare Fund-Growth Option- Direct.
- Sun Pharmaceuticals Industries Ltd: 9.37%
- Ajanta Pharma Ltd: 7.16%
- Lupin Ltd: 5.65%
- Glenmark Pharmaceuticals Ltd: 4.06%
- Gland Pharma Ltd: 3.60%
AMC Information
| Name | UTI Asset Management Co Ltd |
|---|---|
| Founding Date | 2013-01-01 |
| pms_care@uti.co.in | |
| Phone | +91-22-6678 6666 |
| Website | https://www.utiwms.com |
| Address | PMS Division, UTI - Tower, “Gn” Block, Bandra Kurla Complex, Mumbai- 400051 |
Tax Implications of UTI Healthcare Fund-Growth Option- Direct
| Short Term Gains | 20% + applicable Surcharge + 4% Cess |
|---|---|
| Long Term Gains | 12.5% without indexation + applicable Surcharge + 4% Cess |
Similar Funds from UTI Asset Management Co Ltd
UTI Conservative Hybrid Fund Regluar Plan Growth
AllocationConservative Allocation
3Y CAGR
9.49%
expense ratio
1.80%
fund size
₹1703.12 Cr
UTI MNC Fund Regular Plan Growth
EquityEquity - Other
3Y CAGR
13.30%
expense ratio
2.02%
fund size
₹2856.33 Cr
UTI Large cap Fund Regular Plan Growth
EquityLarge-Cap
3Y CAGR
13.42%
expense ratio
1.74%
fund size
₹13321.57 Cr
UTI Mid Cap Fund Regular Plan Growth
EquityMid-Cap
3Y CAGR
16.76%
expense ratio
1.75%
fund size
₹11956.07 Cr
UTI Value fund Fund-Direct Growth Option
EquityValue
3Y CAGR
19.41%
expense ratio
1.19%
fund size
₹10150.97 Cr
Calculate Your Returns
Estimated Returns in 3 Years (Based on past 3Y returns)
₹0
Total Amount
₹0
